Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean J Yoder

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Plos One|January 22, 2015
A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasJennifer Permuth-Wey, Y Ann Chen, Kate Fisher, et al.
European Urology Focus|May 17, 2021
Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Ali Hajiran, Youngchul Kim, et al.
G3 (Bethesda, Md.)|December 1, 2022
A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasmsMargaret A Park, Thinzar Zaw, Sean J Yoder, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 10, 2020
Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreasFrancisca Beato, Dayana Reverón, Kaleena B Dezsi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2017
Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer PatientsNicholas T Gimbrone, Bhaswati Sarcar, Edna R Gordian, et al.
Thyroid : Official Journal of the American Thyroid Association|July 22, 2020
Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and <i>RAS</i> MutationsJuan C Hernandez-Prera, Pablo Valderrabano, Jordan H Creed, et al.
Journal for Immunotherapy of Cancer|July 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencingXiaoqing Yu, Michael D Jain, Meghan A Menges, et al.
Blood|September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapyMark B Meads, Xiaohong Zhao, David R Noyes, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Plos One|January 22, 2015
A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasJennifer Permuth-Wey, Y Ann Chen, Kate Fisher, et al.
European Urology Focus|May 17, 2021
Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Ali Hajiran, Youngchul Kim, et al.
G3 (Bethesda, Md.)|December 1, 2022
A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasmsMargaret A Park, Thinzar Zaw, Sean J Yoder, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 10, 2020
Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreasFrancisca Beato, Dayana Reverón, Kaleena B Dezsi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2017
Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer PatientsNicholas T Gimbrone, Bhaswati Sarcar, Edna R Gordian, et al.
Thyroid : Official Journal of the American Thyroid Association|July 22, 2020
Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and <i>RAS</i> MutationsJuan C Hernandez-Prera, Pablo Valderrabano, Jordan H Creed, et al.
Journal for Immunotherapy of Cancer|July 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencingXiaoqing Yu, Michael D Jain, Meghan A Menges, et al.
Blood|September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapyMark B Meads, Xiaohong Zhao, David R Noyes, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
Pageof 6